FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to a pharmaceutical composition for prevention or treatment of skin diseases containing an effective amount of an antibody or a fragment thereof specifically binding to the SEQ ID NO:1 peptide and a pharmaceutically acceptable carrier, wherein the skin disease constitutes lichen rosacea, herpes zoster, lichen simplex chronicus, herpes simplex, numullary eczema, eczema, molluscum contagiosum, psoriasis, common warts, atopic dermatitis or allergic contact dermatitis, as well as a quasi-medical composition, a preparation for cutaneous use, a method of preventing or treating skin diseases and the use of the described composition for preventing or treating skin diseases and for manufacture of a medicinal product and manufacture of quasi-medicinal products or preparations for cutaneous use.
EFFECT: proposed is pharmaceutical composition aiding in prevention and treatment of skin diseases.
11 cl, 28 dwg, 8 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW O-SUCCINYL HOMOSERINE TRANSFERASE VARIANT AND METHOD FOR SYNTHESIS OF O-SUCCINYL HOMOSERINE USING SAID VARIANT | 2018 |
|
RU2747493C1 |
| PROGRAMMED CELL DEATH (PD-1) PROTEIN-1 ANTIBODIES AND USE THEREOF | 2017 |
|
RU2725950C1 |
| NEW O-SUCCINYL HOMOSERINE TRANSFERASE MUTANT AND METHOD FOR SYNTHESIS OF O-SUCCINYL HOMOSERINE USING SAID MUTANT | 2018 |
|
RU2747494C1 |
| NEW VERSIONS OF HYALURONIDASE WITH IMPROVED STABILITY AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2021 |
|
RU2811464C2 |
| MUTATED SPOT PROTEIN AND METHOD OF PRODUCING L-AMINO ACIDS USING SAME | 2022 |
|
RU2837657C2 |
| ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF | 2020 |
|
RU2831838C2 |
| ANTI-C10orf54 ANTIBODIES AND APPLICATIONS THEREOF | 2015 |
|
RU2819627C1 |
| NEW VARIANT OF L-TYROSINE-EXPORTING PROTEIN AND METHOD OF OBTAINING L-TYROSINE USING IT | 2021 |
|
RU2808831C1 |
| BISPECIFIC ANTI-EGFR/ANTI-4-1BB ANTIBODY AND USE THEREOF | 2020 |
|
RU2831836C2 |
| ANTIBODIES AGAINST LIGAND-1 PROGRAMMED DEATH (PD-L1) AND APPLICATION THEREOF | 2017 |
|
RU2721582C1 |
